Columbia University at CTAD 2026

Nov 16–19, 2026 Boston, MA ~1.7k attendees Website

Columbia University takes part in 6 sessions at CTAD 2026 in Boston. Its program centres on plasma biomarkers and genetic risk, from APOE genotype to polygenic scores. Its work also covers blood-brain barrier repair in APOE4 models and a small molecule aimed at APOE4-related vascular dysfunction.

Organization	CTAD 2026 Attendance
Columbia University New York, New York
columbia.edu Universities & institutes Home of the Taub Institute for Research on Alzheimer's Disease and the Aging Brain and an Alzheimer's Disease Research Center.	Poster Mon Nov 16 – Tue Nov 17 2:00pm Mon – 5:30pm Tue Plasma Biomarker Screening for Amyloid Status in the BenfoTeam randomized controlled trial in Early Alzheimer’s Disease (P006) Blood and CSF biomarkers · Trial design and endpoints Poster Mon Nov 16 – Tue Nov 17 2:00pm Mon – 5:30pm Tue Systemic inflammation and longitudinal trajectory of cognition and blood-based biomarkers of Alzheimer’s Disease in a multiethnic community-based cohort (P144) Prevention and early disease · Blood and CSF biomarkers Poster Mon Nov 16 – Tue Nov 17 2:00pm Mon – 5:30pm Tue Pathology-Informed Polygenic Scores Identify Distinct Genetic Contributors to Alzheimer’s and Non-Alzheimer’s Dementia Across Ancestries (P146) Prevention and early disease Poster Mon Nov 16 – Tue Nov 17 2:00pm Mon – 5:30pm Tue Modulation of Fibronectin-1 Restores Blood-Brain Barrier Integrity and Gliovascular Signaling in APOEβ4-Associated Alzheimer’s Disease (P172) Other mechanisms and targets Talk Wed Nov 18 11:40am Using Plasma P-tau217 and APOE Genotype to Predict Onset of Symptoms of Alzheimer’s Disease Blood and CSF biomarkers · Prevention and early disease Talk Wed Nov 18 5:02pm A First-in-Class CNS-Penetrant Small Molecule Targeting APOE4-mediated Neurovascular Dysfunction in Alzheimer’s Disease Other mechanisms and targets

Organization

CTAD 2026 Attendance

Columbia University

New York, New York

columbia.edu

Universities & institutes

Home of the Taub Institute for Research on Alzheimer's Disease and the Aging Brain and an Alzheimer's Disease Research Center.

Poster

Mon Nov 16 – Tue Nov 17
2:00pm Mon – 5:30pm Tue

Plasma Biomarker Screening for Amyloid Status in the BenfoTeam randomized controlled trial in Early Alzheimer’s Disease (P006)

Blood and CSF biomarkers · Trial design and endpoints

Poster

Mon Nov 16 – Tue Nov 17
2:00pm Mon – 5:30pm Tue

Systemic inflammation and longitudinal trajectory of cognition and blood-based biomarkers of Alzheimer’s Disease in a multiethnic community-based cohort (P144)

Prevention and early disease · Blood and CSF biomarkers

Poster

Mon Nov 16 – Tue Nov 17
2:00pm Mon – 5:30pm Tue

Pathology-Informed Polygenic Scores Identify Distinct Genetic Contributors to Alzheimer’s and Non-Alzheimer’s Dementia Across Ancestries (P146)

Prevention and early disease

Poster

Mon Nov 16 – Tue Nov 17
2:00pm Mon – 5:30pm Tue

Modulation of Fibronectin-1 Restores Blood-Brain Barrier Integrity and Gliovascular Signaling in APOEβ4-Associated Alzheimer’s Disease (P172)

Other mechanisms and targets

Talk

Wed Nov 18
11:40am

Using Plasma P-tau217 and APOE Genotype to Predict Onset of Symptoms of Alzheimer’s Disease

Blood and CSF biomarkers · Prevention and early disease

Talk

Wed Nov 18
5:02pm

A First-in-Class CNS-Penetrant Small Molecule Targeting APOE4-mediated Neurovascular Dysfunction in Alzheimer’s Disease

Other mechanisms and targets

Instantly find 20 buyers from Columbia University

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by the CTAD Conference. Organization details are derived from CTAD’s published program, poster list and sponsor page. Submit a correction